Leal Health

The company's core offering is a sophisticated decision-support platform that serves multiple stakeholders: patients, healthcare providers, and pharmaceutical companies. For patients, the platform analyzes their specific medical records, including complex genetic data, to generate a personalized and easy-to-understand list of all relevant treatment options, including FDA-approved therapies and clinical trials. A key feature is its predictive capability, which can anticipate future treatment needs as a patient's disease progresses. The service also provides resources for financial aid and schedule management to remove common barriers to care.

For its business clients in the pharmaceutical and biotech industries, Leal Health provides a platform to enhance the design and recruitment for clinical trials. By offering analytics on patient populations and barriers, it helps these companies develop more patient-centric trials, identify suitable candidates more efficiently, and ultimately reduce the time and cost associated with bringing new drugs to market. This dual B2B and B2C model positions the company as a central hub in the oncology ecosystem. The company has received numerous accolades, including being named one of TIME's 100 Best Inventions of 2020 and an honoree in Fast Company's 2021 World-Changing Ideas Awards.